Totally plc Stocks

£ 0Last Updated 03.07.2025

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

£ 629265.142

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
£ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Totally plc, through its subsidiaries, provides out-of-hospital healthcare services in the United Kingdom and Ireland. It operates through Urgent Care, Planned Care, and Insourcing segments. The company offers a range of treatment and advice for musculoskeletal injuries and conditions, such as physiotherapy and podiatry to NHS patients; fitness, and occupational health and ergonomic services to corporate and private clients. It also provides dermatology and referral management services; urgent care services; and clinical health coaching services to educate patients to self-manage their conditions, such as chronic obstructive pulmonary disease; and hospital insourcing services, as well as IT healthcare solutions; and provision for online health and safety risk assessments. The company was incorporated in 1999 and is based in Derby, the United Kingdom.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks